Stelvio Ballanti

Treatment of High-Risk Acute Leukemia with T-Cell–Depleted Stem Cells from Related Donors with One Fully Mismatched HLA Haplotype

Franco Aversa, Antonio Tabilio, Andrea Velardi et al. · New England Journal of Medicine · 1998 · 1.2K citations · Full text

Medicine, Hematology, Oncology +17

Full Haplotype-Mismatched Hematopoietic Stem-Cell Transplantation: A Phase II Study in Patients With Acute Leukemia at High Risk of Relapse

Franco Aversa, Adelmo Terenzi, Antonio Tabilio et al. · Journal of Clinical Oncology · 2005 · 704 citations

Medicine, Hematology, Oncology +17

Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study

Michèle Cavo, Francesca Gay, Meral Beksaç et al. · The Lancet Haematology · 2020 · 384 citations · Full text

Medicine, Hematology, Oncology +17

Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma

Michèle Cavo, Lucia Pantani, Maria Teresa Petrucci et al. · Blood · 2012 · 309 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria

Chiara Cattaneo, Roberta Di Blasi, Cristina Skert et al. · Annals of Hematology · 2018 · 117 citations · Full text

Medicine, Hematology, Oncology +16